Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
CTI BioPharma Corp. (CTIC)
NASDAQ:CTIC
CTI BioPharma (CTIC) Stock Price & Analysis
868 Followers
CTIC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.01 - $9.06
Previous Close$9.05
Volume3.07M
Average Volume (3M)5.88M
Market Cap
$1.19B
Enterprise Value$1.18B
Total Cash (Recent Filing)$59.01M
Total Debt (Recent Filing)$48.08M
Price to Earnings (P/E)-15.7
Beta0.19
Next Earnings
Aug 03, 2023EPS Estimate
-$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding131,880,176
10 Day Avg. Volume3,022,710
30 Day Avg. Volume5,880,400
Standard Deviation0.33
R-Squared0.02
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)-24.82
Price to Sales (P/S)49.49
Price to Cash Flow (P/CF)-9.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue15.61
Enterprise Value/Gross Profit23.45
Enterprise Value/Ebitda76.21
Forecast
1Y Price Target
$9.63Price Target Upside6.41% Upside
Rating ConsensusHold
Number of Analyst Covering8
CTI BioPharma News
Press ReleasesSobi to Acquire CTI BioPharma
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CTIC FAQ
What was CTI BioPharma Corp.’s price range in the past 12 months?
CTI BioPharma Corp. lowest stock price was $4.00 and its highest was $9.05 in the past 12 months.
What is CTI BioPharma Corp.’s market cap?
Currently, no data Available
When is CTI BioPharma Corp.’s upcoming earnings report date?
CTI BioPharma Corp.’s upcoming earnings report date is Aug 03, 2023 which is in 58 days.
How were CTI BioPharma Corp.’s earnings last quarter?
CTI BioPharma Corp. released its earnings results on May 11, 2023. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.114 by $0.014.
Is CTI BioPharma Corp. overvalued?
According to Wall Street analysts CTI BioPharma Corp.’s price is currently Undervalued.
Does CTI BioPharma Corp. pay dividends?
CTI BioPharma Corp. does not currently pay dividends.
What is CTI BioPharma Corp.’s EPS estimate?
CTI BioPharma Corp.’s EPS estimate is -$0.08.
How many shares outstanding does CTI BioPharma Corp. have?
CTI BioPharma Corp. has 131,880,170 shares outstanding.
What happened to CTI BioPharma Corp.’s price movement after its last earnings report?
CTI BioPharma Corp. reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.114. Following the earnings report the stock price went up 0.224%.
Which hedge fund is a major shareholder of CTI BioPharma Corp.?
Among the largest hedge funds holding CTI BioPharma Corp.’s share is Perceptive Advisors LLC. It holds CTI BioPharma Corp.’s shares valued at N/A.
---
CTI BioPharma Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$9.63 (6.41% Upside)
$9.63 (6.41% Upside)
Blogger Sentiment
Bullish
CTIC Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 2.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.84%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-14.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CTI BioPharma Corp.
CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.
---
Top 5 ETFs holding CTIC
Vanguard Total Stock Market ETF
$18.09M
iShares Core S&P Total U.S. Stock Market ETF
$839.02K
Fidelity MSCI Health Care Index ETF
$485.25K
iShares Russell 3000 ETF
$259.61K
Vanguard Russell 3000 ETF
$40.17K
Up to five ETFs with an Outperform Smart Score that hold CTIC. The ETFs are listed according to market value of CTIC within the ETF
---
CytomX Therapeutics
―
Molecular Templates
―
Onconova Therapeutics
―
SELLAS Life Sciences Group
―
---